KDP vs MNPR · P/E 23, rev $11.29B vs $431.4M cap
Keurig Dr Pepper Inc (KDP) versus Monopar Therapeutics Inc (MNPR) — a side-by-side from cached financials, not a winner call.
Keurig Dr Pepper Inc (KDP) is a beverages - non-alcoholic company listed on NASDAQ.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Latest reported KDP revenue for 2026-06-30 was $11.29B. Net income was $412.0M. KDP currently screens at market cap $42.03B and trailing P/E 22.9.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
KDP currently screens at market cap $42.03B and trailing P/E 22.9. MNPR currently screens at market cap $431.4M.
Not investment advice. Open the KDP and MNPR stock pages for the full models.
Not investment advice.